NYSE · Healthcare · Biotechnology
Nuvation Bio Inc.
NUVB
Nuvation Bio Inc. CEO David T. Hung · Market cap $2.0B.
$5.65
-0.16 · -2.75%
52w hi $9.7552w lo $1.86
Off 52w high 51.2%
56
ROUTINE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
Strong Buy
Avg PT $13.00
Section 01
Recent Form 4 filings
8 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jun 09 | Robert Mashal | Buy | 25,000 | $4.73 | +$118K | 56 | |
| Dec 01 | Dongfang Liu | CHIEF MEDICAL OFFICER | Sell | 150,000 | $7.82 | −$1.17M | 37 |
| Nov 20 | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Sell | 300,000 | $7.23 | −$2.17M | 37 |
| Nov 19 | David C. Hanley | CHIEF TECHNICAL OPERATIONS | Sell | 200,000 | $7.14 | −$1.43M | 37 |
| Jun 16 | David Hung | PRESIDENT AND CEO | Buy | 500,000 | $1.79 | +$894K | 77 |
| Jun 16 | Colleen Sjogren | Chief Commercial Officer | Buy | 50,000 | $1.81 | +$90K | 77 |
| Jun 16 | Kerry Wentworth | CHIEF REGULATORY OFFICER | Buy | 26,000 | $1.79 | +$47K | 75 |
| Jun 16 | Kerry Wentworth | CHIEF REGULATORY OFFICER | Buy | 24,000 | $1.80 | +$43K | 75 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun